Multiple myeloma science from EHA 2019
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
20 Jun 2019
CAR T-cell therapy for treating acute leukaemia
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
20 Jun 2019
Selinexor plus cytarabine and idarubicin in patients with relapsed/refractory ac...
Prof Walter Fiedler - University of Hamburg, Hamburg, Germany
20 Jun 2019
ECHELON-1 study 3 year update: Frontline brentuximab vedotin with chemotherapy f...
Dr Andrea Gallamini - Centre Antoine Lacassagne, Nice, France
20 Jun 2019
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy f...
Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China
20 Jun 2019
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dos...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
20 Jun 2019
HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
20 Jun 2019
PET after 2 cycles of ABVD in patients with early-stage favourable Hodgkin lymph...
Michael Fuchs - University Hospital of Cologne, Cologne, Germany
20 Jun 2019
Safety and efficacy of escalating doses of Hu5F9-G4 with rituximab in patients w...
Dr Mark Roschewski - National Cancer Institute, Bethesda, USA
20 Jun 2019
Combination of pegcrisantaspase and venetoclax in acute myeloid leukaemia
Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
20 Jun 2019
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
20 Jun 2019
Chemoimmunotherapy or BTK inhibition for patients with CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
20 Jun 2019
